Life-Threatening Arrhythmia in Ebstein’s Anomaly: A Rare Cardiovascular Presentation of Williams Syndrome – A Case Study - Top-Institutions - MDSpire

Life-Threatening Arrhythmia in Ebstein’s Anomaly: A Rare Cardiovascular Presentation of Williams Syndrome – A Case Study

  • By

  • M. E. Schouw

  • T. T. Koopmann

  • N. A. Blom

  • J. L. Stöger

  • D. Q. C. M. Barge-Schaapveld

  • R. Bökenkamp

  • March 2, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Boston Children's Hospital
    Boston Children's Hospital

    Boston, MA

    Key Differentiators

    • Pediatric Cardiology
    • Genetic Cardiovascular Disorders
    • Cardiac Electrophysiology

  • #2

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Cardiology
    • Clinical Genetics
    • Cardiac Electrophysiology

  • #3

    Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical Center

    Cincinnati, OH

    Key Differentiators

    • Pediatric Cardiology
    • Genetic Syndromes
    • Cardiac Electrophysiology

  • #4

    Texas Children's Hospital
    Texas Children's Hospital

    Houston, TX

    Key Differentiators

    • Pediatric Cardiology
    • Genetic Cardiovascular Disorders
    • Electrophysiology

Original Source(s)

Life-Threatening Arrhythmia in Ebstein’s Anomaly: A Rare Cardiovascular Presentation of Williams Syndrome – A Case Study

  • by M. E. Schouw, T. T. Koopmann, N. A. Blom, J. L. Stöger, D. Q. C. M. Barge-Schaapveld, R. Bökenkamp

  • March 2, 2026

Related Content

Long COVID May Raise Cardiovascular Risk

Population-based cohort shows higher rates of cardiac arrhythmias and coronary artery disease following nonhospitalized infections, with sex-specific differences.

Is Long COVID Affecting the Heart?

Study points to increased cardiovascular events post-infection

  • April 17, 2026

  • 2 min
AF Stroke Prevention: Testing Ablation

In the randomized STABLED trial, adding catheter ablation to edoxaban did not reduce recurrent stroke or major cardiovascular outcomes.